Application of management guidelines to the assessment of new medicines: driving us forward or holding us back?

Calverley P.M.A., Rennard S.I.

Source: Eur Respir J 2004; 23: 793-794
Journal Issue: June

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Calverley P.M.A., Rennard S.I.. Application of management guidelines to the assessment of new medicines: driving us forward or holding us back?. Eur Respir J 2004; 23: 793-794

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is our approach to basic research right? Pitfalls and successes: what is the way forward?
Source: ERS Research Seminar 2016
Year: 2016

Telemonitoring in clinical practice: a way forward?
Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice"
Year: 2013


Rational monitoring of COPD: where do current clinical guidelines stand?
Source: Eur Respir J 2007; 29: 1078-1081
Year: 2007


Personalised medicine: a step forward to better care?
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013



Getting approval for new therapeutic medical devices versus drugs: are the differences justified?
Source: Eur Respir Rev 2016; 25: 223-226
Year: 2016


The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017



An evidence-based, point-of-care tool to guide completion of asthma action plans in practice
Source: Eur Respir J, 49 (5) 1602238; 10.1183/13993003.02238-2016
Year: 2017




Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation
Source: Eur Respir J 2014; 44: 1412-1417
Year: 2014


Implementing the BTS COPD guidelines: how far have we come?
Source: Eur Respir J 2002; 20: Suppl. 38, 254s
Year: 2002

How do the new guidelines work? Practical approach to the new guidelines for asthma diagnosis in children, discussion and Q&A
Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years
Year: 2021


Rethinking the way we are treating established airway disease: current guidelines need to change 
Source: International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma
Year: 2016


COPD self management: The impact of implementing self management plans & rescue medications across 3 hospitals
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012


Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement
Source: Eur Respir J 2016; 47:1336-1341
Year: 2016


Maintaining currency and improving utility of COPD guidelines: an achievable goal?
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009

Adding biological markers to COPD categorisation schemes: a way towards more personalised care?
Source: Eur Respir J 2016; 47:1601-1605
Year: 2016


Respiratory medicines for children: current evidence, unlicensed use and research priorities
Source: Eur Respir J 2010; 35: 247-265
Year: 2010



Digital health technology for the end TB strategy: Developing priority products and making them work
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016